Skip to content
healthcare.dev

DEFERASIROX

NDC 46708-410, DEFERASIROX, tablet, film coated, from Alembic Pharmaceuticals Limited.

Product NDC
46708-410
Status
Listed
Labeler
Alembic Pharmaceuticals Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211824
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/46708-410 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFERASIROX90 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
46708-410-304670804103030 TABLET, FILM COATED in 1 BOTTLE (46708-410-30)
46708-410-91467080410911000 TABLET, FILM COATED in 1 BOTTLE (46708-410-91)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/dd9450f4-7c95-4322-8806-9820570f5aa2

Use it

Look up 46708-410 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/46708-410 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 46708-410. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.